Eliminating cold chain requirements

Our novel platforms enable temperature stable products that can be transported and stored at ambient temperatures.

  • Our novel freeze-dried saRNA/NLC vaccines can be stored for at least six months at ambient temperatures and up to a year in simple refrigeration, so they can be distributed to areas of unmet need, including those parts of the world without deep cold chain infrastructure.
  • We created innovative dry powder formulations of immune-stimulating adjuvants that remain stable at ambient temperatures for up to three months.